Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
HEALTH
AstraZeneca drops partnership with Regulus after ditching drug
By Melissa Angell
Jun 13, 2017 1:12 PM EDT
PRESS RELEASES
Regulus Therapeutics Announces Closing Of $19.4 Million Private Placement Of Equity
By PR Newswire
Dec 8, 2020 8:07 AM EST
PRESS RELEASES
Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development
By PR Newswire
Dec 2, 2020 7:00 AM EST
PRESS RELEASES
Regulus Therapeutics Announces Private Placement Of Equity
By PR Newswire
Dec 1, 2020 8:35 AM EST
PRESS RELEASES
Regulus Therapeutics Announces Achievement Of Interim Enrollment Milestone Under Collaboration With Sanofi
By PR Newswire
Nov 2, 2020 8:07 AM EST
PRESS RELEASES
Regulus Therapeutics Announces First Patient Dosed In Phase 1b Clinical Trial Of RGLS4326 For The Treatment Of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
By PR Newswire
Oct 15, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics Announces Receipt Of $5 Million Milestone And Material Payments From Sanofi
By PR Newswire
Oct 13, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics To Present At The 2020 Wells Fargo Virtual Healthcare Conference
By PR Newswire
Sep 3, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics Announces Restructuring Of Sanofi And Oxford Loan Agreements
By PR Newswire
Aug 31, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics To Present At The 2020 Wedbush PacGrow Healthcare Virtual Conference
By PR Newswire
Aug 6, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics Appoints Denis Drygin, Ph.D., As Chief Scientific Officer
By PR Newswire
Aug 3, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics Announces FDA Orphan Drug Designation Of RGLS4326 For The Treatment Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
By PR Newswire
Jul 29, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics Completes Dosing In Phase 1 Multiple Ascending Dose Study Of RGLS4326 In Healthy Volunteers For The Treatment Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
By PR Newswire
Jul 22, 2020 8:07 AM EDT
PRESS RELEASES
Regulus Therapeutics Reinitiates Multiple Ascending Dose Study Of RGLS4326 For The Treatment Of ADPKD
By PR Newswire
Feb 13, 2020 4:30 PM EST
PRESS RELEASES
Regulus Therapeutics Announces FDA Removal Of Partial Clinical Hold For Multiple Ascending Dose Study Of RGLS4326
By PR Newswire
Dec 16, 2019 8:00 AM EST
HEALTH
AstraZeneca drops partnership with Regulus after ditching drug
By Melissa Angell
Jun 13, 2017 1:12 PM EDT
MARKETS
Regulus Therapeutics (RGLS): Today's Weak On High Volume Stock
By TheStreet Wire
Jun 1, 2016 10:02 AM EDT
MARKETS
Regulus Therapeutics (RGLS): Today's Weak On High Volume Stock
By TheStreet Wire
Apr 27, 2016 10:04 AM EDT
MARKETS
Regulus Therapeutics (RGLS) Is Strong On High Volume Today
By TheStreet Wire
Apr 21, 2016 10:01 AM EDT
MARKETS
Regulus Therapeutics (RGLS) Is Weak On High Volume Today
By TheStreet Wire
Apr 18, 2016 10:09 AM EDT
MARKETS
Insider Trading Alert - AIRM, RGLS And AAON Traded By Insiders
By TheStreet Wire
Mar 8, 2016 11:00 AM EST
MARKETS
Regulus Therapeutics (RGLS) Is Today's Dead Cat Bounce Stock
By TheStreet Wire
Feb 26, 2016 10:06 AM EST
MARKETS
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
By TheStreet Wire
Feb 25, 2016 11:45 AM EST
OPINION
4 momentum stocks making strong moves to watch
By Harry Boxer
Feb 18, 2016 12:39 PM EST
MARKETS
Regulus (RGLS) Stock Soars on Interim Trial Results for Hepatitis C Virus Treatment
By Amanda Albright
Feb 17, 2016 11:12 AM EST
